骨形成蛋白6(BMP6)多克隆抗體(生物素標記)
Biotin-Linked Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
VGR; VGR1; Vegetal Related Growth Factor(TGFB-Related); VG-1-related protein
- 編號LAA646Ra71
- 物種Rattus norvegicus (Rat，大鼠) 相同的名稱，不同的物種。
- 來源抗體標記
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物生物素
- 原抗體 -
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 677 ¥ 1579 ¥ 2256 ¥ 5640 ¥ 22560
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Western Blot; Sample: Rat Serum
Primary Ab: 0.2μg/ml Biotin-Linked Polyclonal Antibody to Bone Morphogenetic Protein 6 (BMP6)
Second Ab: 0.2μg/ml HRP-Labeled Streptavidin (Catalog: IS089)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對BMP6的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別BMP6。
用法
免疫印跡：0.2-2μg/mL;1:250-2500
免疫組織化學：5-20μg/mL;1:25-100
免疫細胞化學：5-20μg/mL;1:25-100
最佳稀釋倍數最終由用戶決定。
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Rattus norvegicus (Rat，大鼠) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPA646Ra01 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA646Ra01 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA646Ra71 | 骨形成蛋白6(BMP6)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAA646Ra21 | 骨形成蛋白6(BMP6)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA646Ra | 骨形成蛋白6(BMP6)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA646Ra | 骨形成蛋白6(BMP6)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity [PubMed: 23452891] |
| Polskie Archiwum Medycyny Wewn Trznej | New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis [PubMed: 23111696] |
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches [Plosone: Source] |
| journal of biomedical materials research part b-applied biomaterials | In vitro chondrogenesis by BMP6 gene therapy [Pubmed: 23077084] |
| Journal of Clinical Pathology | Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C [PubMed: 26290259] |
| Clinical?and Experimental Pharmacology and Physiology | Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure [pubmed:27592865] |
| International Journal of Biological Macromolecules | SEQUENTIAL IGF-1 AND BMP-6 RELEASING CHITOSAN/ALGINATE/PLGA HYBRID SCAFFOLDS FOR PERIODONTAL REGENERATION [pubmed:28601648] |
| Elife | The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium [Pubmed:29749927] |
留言咨詢
